Summit Investment Advisors »

Neumora Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $26k 1.5k 17.05

More positions owned by Summit Investment Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Europe Pacific ETF (VEA)
Ishares Tr Etf (IVV)
Amazon (AMZN)
Vanguard S&p 500 Etf idx (VOO)
iShares Lehman Aggregate Bond (AGG)
NVIDIA Corporation (NVDA)
Alphabet Inc Class C cs (GOOG)
Spdr Ser Tr Etf (ONEV)
iShares S&P 500 Growth Index (IVW)
Broadcom (AVGO)
Vanguard Total Bond Market ETF (BND)
iShares S&P 500 Value Index (IVE)
Facebook Inc cl a (META)

View all positions for Summit Investment Advisors

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Artal Group
EcoR1 Capital
Avidity Partners Management
Citadel Advisors
Hillhouse Capital Advisors
OrbiMed Advisors
Goldman Sachs Group
Logos Global Management
Vanguard Group
Addis & Hill
Schonfeld Strategic Advisors
Pier Capital

View all funds holding Neumora Therapeutics